Hologic, Inc. (NASDAQ:HOLX) was the recipient of a significant increase in short interest in October. As of October 31st, there was short interest totalling 10,839,458 shares, an increase of 28.9% from the October 13th total of 8,411,957 shares. Approximately 3.9% of the company’s stock are sold short. Based on an average daily trading volume, of 2,698,364 shares, the short-interest ratio is currently 4.0 days.

Hologic (NASDAQ HOLX) opened at $40.64 on Tuesday. The firm has a market cap of $10,723.51, a P/E ratio of 19.29, a price-to-earnings-growth ratio of 1.88 and a beta of 0.93. Hologic has a 12-month low of $35.76 and a 12-month high of $46.80. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.79 and a quick ratio of 0.61.

Hologic (NASDAQ:HOLX) last posted its quarterly earnings results on Wednesday, November 8th. The medical equipment provider reported $0.50 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.49 by $0.01. The business had revenue of $802.90 million during the quarter, compared to analyst estimates of $792.54 million. Hologic had a net margin of 24.70% and a return on equity of 21.69%. The company’s revenue was up 10.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.52 earnings per share. sell-side analysts anticipate that Hologic will post 2.12 EPS for the current year.

Several research firms have recently weighed in on HOLX. Zacks Investment Research raised shares of Hologic from a “sell” rating to a “hold” rating in a report on Tuesday, October 31st. Needham & Company LLC reissued a “buy” rating and set a $50.00 price objective on shares of Hologic in a report on Friday, November 3rd. Barclays PLC reissued an “overweight” rating and set a $53.00 price objective (up from $50.00) on shares of Hologic in a report on Monday, July 17th. BidaskClub cut shares of Hologic from a “buy” rating to a “hold” rating in a report on Wednesday, August 2nd. Finally, Bank of America Corporation reissued a “neutral” rating and set a $48.00 price objective (up from $44.00) on shares of Hologic in a report on Friday, July 21st. One investment analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $47.54.

In other news, VP Karleen Marie Oberton sold 1,256 shares of the business’s stock in a transaction that occurred on Wednesday, November 8th. The shares were sold at an average price of $39.29, for a total transaction of $49,348.24. Following the completion of the transaction, the vice president now directly owns 9,406 shares of the company’s stock, valued at $369,561.74. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Lawrence M. Levy sold 9,596 shares of the business’s stock in a transaction that occurred on Tuesday, October 10th. The shares were sold at an average price of $36.81, for a total transaction of $353,228.76. The disclosure for this sale can be found here. In the last quarter, insiders sold 25,667 shares of company stock worth $969,299. Insiders own 0.79% of the company’s stock.

Several large investors have recently modified their holdings of the stock. Stratos Wealth Partners LTD. boosted its position in shares of Hologic by 0.6% during the second quarter. Stratos Wealth Partners LTD. now owns 4,954 shares of the medical equipment provider’s stock worth $225,000 after acquiring an additional 30 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of Hologic by 0.4% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 20,803 shares of the medical equipment provider’s stock worth $944,000 after acquiring an additional 85 shares during the last quarter. Symphony Asset Management LLC boosted its position in shares of Hologic by 0.4% during the second quarter. Symphony Asset Management LLC now owns 28,005 shares of the medical equipment provider’s stock worth $1,271,000 after acquiring an additional 108 shares during the last quarter. Cutter & CO Brokerage Inc. boosted its position in shares of Hologic by 1.7% during the second quarter. Cutter & CO Brokerage Inc. now owns 11,530 shares of the medical equipment provider’s stock worth $523,000 after acquiring an additional 190 shares during the last quarter. Finally, Louisiana State Employees Retirement System boosted its position in shares of Hologic by 1.2% during the second quarter. Louisiana State Employees Retirement System now owns 17,400 shares of the medical equipment provider’s stock worth $790,000 after acquiring an additional 200 shares during the last quarter. Hedge funds and other institutional investors own 96.41% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece was first published by Daily Political and is the property of of Daily Political. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The correct version of this piece can be accessed at https://www.dailypolitical.com/2017/11/14/short-interest-in-hologic-inc-holx-grows-by-28-9.html.

About Hologic

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.

Receive News & Ratings for Hologic Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic Inc. and related companies with MarketBeat.com's FREE daily email newsletter.